Halo Labs is a Burlingame, CA-based life science instrumentation and consumable company led by CEO Rick Gordon. It commercializes the Aura platform for high-throughput aggregate, visible and subvisible particle analysis used in biopharmaceutical formulation, stability testing, and product quality control. The technology uses custom optics and image-processing techniques to perform optical imaging on membranes, providing researchers insights into aggregates and subvisible particles present in drug products. The company closed a $6M Series C growth financing led by Agilent Technologies, with participation from Research Corporation Technologies, Broad Oak Capital Partners, and BioAdvance. Halo Labs intends to use the proceeds to continue commercialization of the Aura platform, increase manufacturing capacity, and develop new products to meet current and emerging needs of pharmaceutical researchers. Halo Labs, led by CEO Robert Wicke and based in Burlingame, Calif., develops scientific instrumentation and consumables for biologics researchers. It commercializes high-throughput biopharmaceutical formulation and quality-control tools for subvisible particle (SVP) analysis using custom optics and image-processing techniques. Its Horizon® instrument performs high-throughput SVP analysis with volumes as low as 25 µL and uses a 96-well membrane plate to test several parameters quickly without dilution or sample preparation. The company closed a $12M Series B1 financing to support growth. Halo intends to use the funds to expand its worldwide sales presence, continue development of its next-generation product portfolio, and acquire complementary technologies and companies to expand into the analytical particle space. Halo Labs develops the Horizon® instrument, which enables high-throughput, low-volume subvisible particle analysis for biologics researchers using sample volumes as low as 25 µL. The company focuses on tools for biologics researchers and is commercializing instruments that perform subvisible particle analysis at scale. Halo intends to use recent funding to commercialize Horizon and to continue development of its broader product pipeline. Leadership includes CEO Robert Wicke; the company also named Dr. Joseph Keegan Executive Chairman of the Board. Financially, Halo completed a $5.6M Series B financing to support commercialization and product development efforts. The company is based in San Francisco, CA.

Total raised

$24M

Funding rounds

3

Latest round

Series C

Latest activity

Jul 2022